- Home
- FLOC vs BLTE Comparison
FLOC vs BLTE Comparison
Compare FLOC & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLOC
- BLTE
- Stock Information
- Founded
- FLOC 1996
- BLTE 2018
- Country
- FLOC United States
- BLTE United States
- Employees
- FLOC N/A
- BLTE N/A
- Industry
- FLOC Metal Fabrications
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- FLOC Industrials
- BLTE Health Care
- Exchange
- FLOC Nasdaq
- BLTE Nasdaq
- Market Cap
- FLOC 1.9B
- BLTE 2.1B
- IPO Year
- FLOC 2025
- BLTE 2022
- Fundamental
- Price
- FLOC $17.17
- BLTE $65.72
- Analyst Decision
- FLOC Strong Buy
- BLTE Strong Buy
- Analyst Count
- FLOC 5
- BLTE 4
- Target Price
- FLOC $33.40
- BLTE $96.67
- AVG Volume (30 Days)
- FLOC 294.0K
- BLTE 62.6K
- Earning Date
- FLOC 08-05-2025
- BLTE 08-12-2025
- Dividend Yield
- FLOC 1.86%
- BLTE N/A
- EPS Growth
- FLOC N/A
- BLTE N/A
- EPS
- FLOC 2.69
- BLTE N/A
- Revenue
- FLOC $660,916,000.00
- BLTE N/A
- Revenue This Year
- FLOC $51.92
- BLTE N/A
- Revenue Next Year
- FLOC $11.23
- BLTE N/A
- P/E Ratio
- FLOC $6.39
- BLTE N/A
- Revenue Growth
- FLOC 156.58
- BLTE N/A
- 52 Week Low
- FLOC $15.83
- BLTE $43.70
- 52 Week High
- FLOC $30.50
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- FLOC N/A
- BLTE 62.75
- Support Level
- FLOC N/A
- BLTE $63.34
- Resistance Level
- FLOC N/A
- BLTE $62.64
- Average True Range (ATR)
- FLOC 0.00
- BLTE 1.89
- MACD
- FLOC 0.00
- BLTE 0.46
- Stochastic Oscillator
- FLOC 0.00
- BLTE 94.42
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.